Apheresis is various procedures that are carried out to treat multiple neurological, autoimmune, renal, haematological and other diseases. In this process initially, the blood of the patient is entirely taken out from the body. The blood is processed through apheresis machine in which essential blood components are extracted based on the molecular weight, size, and affinity. After this process, remaining purified blood is resent back into the patient’s body. Apheresis is a process in which blood components are separated using centrifugation/ membrane filtration technology. To be more specific, Apheresis are procedures which are used to carry out various blood purification and blood component separation purpose.
Europe Apheresis Market Segments Size & Growth:
Europe Apheresis Market is expected to grow with a CAGR of XX% throughout the forecast period and is anticipated to reach $ XX Billion by 2024. Increasing prevalence regarding various chronic diseases due to the change in the lifestyle of people that is dynamically adopted, rising demand for blood components, increase in the number of complex surgical procedures, increase in government funds, increase in the economies from emerging countries and others are considered as boosting factors for the growth of the market. However, lack of awareness regarding apheresis system, the high cost of Apheresis system equipment and others are considered as challenges for the continuous growth of the market.
Europe Apheresis Market Segments Share:
Based on procedures, this market is divided into Automated/Apheresis Blood Collection, and Therapeutics apheresis. Therapeutics Apheresis is furtherly divided as by Diseases type and by systems type. Under diseases type, Neurological Disorders, Blood Disorders, Renal Disorders, Autoimmune Disorders, and others. Depending upon the form of the procedure, this market is divided as Photopheresis, Extracorporeal Immunoadsorption, Therapeutic Cytapheresis and others. Depending on the product type this market is segmented as Apheresis Devices and Apheresis Disposables. Apheresis Devices can be divided into plasma separators, hemoperfusion Columns, Plasma Component Separators, Immunoadsorption Separators, Plasma Perfusion Columns, and others. Depending upon technology, this market is segmented as Centrifugation and Membrane Separation. Centrifugation is divided into Intermittent Flow and Continuous Flow. Various Applications are there under Apheresis System, few of these include, Plasmapheresis, Plateletpheresis, Erythocytapheresis, Leukapheresis, and others. Hospitals, Blood Collection Centers, Research Institutes and others are considered as few of many End-Users associated with Apheresis Market. Depending upon geography, this market has got its expansion and presence in the regions of North America, Europe, South America, Middle East and Africa and also in the areas of Asia Pacific. The market in Europe is considered to be with one of the most significant market shares.
Europe Apheresis Market Trends:
- Kaneka Corporation las previously launched a protein, chromatography Resin with enhanced Binding Capacity for the purification of Antibody Drugs
- Braun has recently started a new dialyser namely Diacap Pro to provide improved care for Dialysis Patients.
Europe Apheresis Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
Market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary critical players in the Europe Apheresis Market are:
- Fresenius SE & Co. KGaA
- Cerus Corporation
- Asahi Kasei Medical Co., Ltd.
- Haemonetics Corporation
- Kaneka Corporation
- Kawasumi Laboratories Inc.
- Nikkiso Co., Ltd.
Along with these companies, there were many other companies considered/cited in the report while analysing the Europe Apheresis Market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increase Prevalence of Diseases
4.1.2 Rising Demand for Blood Component
4.1.3 Increase in number of Complex Surgical Procedures
4.2 Restraints
4.2.1 Lack of awareness about Apheresis System
4.3 Opportunities
4.3.1 Increase in Government Funds
4.3.2 Increase in economies from emerging countries.
4.4 Challenges
4.4.1 High Cost of Apheresis System Equipment
Chapter 5 Europe Apheresis Market– By Procedures
5.1 Automated/Apheresis Blood Collection
5.2 Therapeutic Apheresis
5.2.1 Therapeutic Apheresis by Diseases
5.2.1.1 Neurological Disorders
5.2.1.2 Blood Disorders
5.2.1.3 Renal Disorders
5.2.1.4 Autoimmune Disorders
5.2.1.5 Others
5.2.2 Therapeutics Apheresis by Procedures
5.2.2.1 Photopheresis
5.2.2.2 Extracorporeal Immunoadsorption
5.2.2.3 Therapeutic Cytapheresis
5.2.2.4 Others
Chapter 6 Europe Apheresis Market– By Product
6.1 Apheresis Devices
6.1.1 Plasma Separators
6.1.2 Hemoperfusion Columns
6.1.3 Plasma Component Separators
6.1.4 Immunoadsorption Columns
6.1.5 Plasma Perfusion Columns
6.2 Apheresis Disposables
Chapter 7 Europe Apheresis Market- By Technology
7.1 Centrifugation
7.1.1 Intermittent Flow
7.1.2 Continuous Flow
7.2 Membrane Separation
Chapter 8 Europe Apheresis Market- By Applications
8.1 Plasmapheresis
8.2 Plateletpheresis
8.3 Erythocytapheresis
8.4 Leukapheresis
8.5 Others
Chapter 9 Europe Apheresis Market- By End – User
9.1 Hospitals
9.2 Blood Collection Centers
9.3 Research Institutes
9.4 Others
Chapter 10 Europe Apheresis Market- By Geography
10.1 Introduction
10.2 Europe
10.2.1 U.K.
10.2.2 Germany
10.2.3 France
10.2.4 Italy
10.2.5 Spain
10.2.6. Others
Chapter 11 Europe Apheresis Market- Company Profiles
11.1 Fresenius SE & Co. KGaA
11.2 Cerus Corporation
11.3 Asahi Kasei Medical Co., Ltd.
11.4 Haemonetics Corporation
11.5 Kaneka Corporation
11.6 Kawasumi Laboratories Inc.
11.7 Nikkiso Co., Ltd.
11.8 Terumo BCT, Inc.
11.9 Hemacare Corporation
11.10 B. Braun Melsungen AG
Chapter 12 Europe Apheresis Market- Competitive Landscape
12.1. Market Share Analysis
12.2. Strategies Adopted by top companies
12.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 13 Market Insights
13.1. Industry Experts Insights
13.2. Analysts Opinions
13.3. Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
IND: (+91) 949418 5556
sales@envisionintelligence.com
Credibility and Transparency
Exhaustive Coverage
Competitive Edge
Golden Opportunities
Top-notch Reports Guaranteed
Post Purchase Support
